ArticleIET nanobiotechnology2016
Biofabrication of broad range antibacterial and antibiofilm silver nanoparticles.
Article in IET nanobiotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Development of poly-D-mannose-stabilized silver nanoparticles exhibiting antibacterial and antibiofilm properties.Applied and environmental microbiology · 2025Article
- Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing.Pharmaceutics · 2024Review
- Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies.Archives of microbiology · 2024Review
- The role of nanocomposites against biofilm infections in humans.Frontiers in cellular and infection microbiology · 2023Review
- Challenges of antibiotic resistance biofilms and potential combating strategies: a review.3 Biotech · 2021Review
- Studies on antimicrobial and wound healing applications of gauze coated with CHX-Ag hybrid NPs.IET nanobiotechnology · 2020Article
- New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics.Current reviews in musculoskeletal medicine · 2018Review
- Obliteration of bacterial growth and biofilm through ROS generation by facilely synthesized green silver nanoparticles.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles (AgNPs) were biosynthesized via a green route using ten different plants extracts (GNP1-
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.